News
TURKU, FI / ACCESS Newswire / May 12, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - BEXMAB data highlights meaningful clinical benefit, with beneficial immunological and hematological impact in ...
Others were characterized by the enrichment of differentiation states from a specific progenitor, such as an erythroid, lymphoid, or myeloid progenitor. Erythroid and lymphoid enrichment were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results